Veos Pharmaceuticals Receives Employment Support Grant from the Community of Madrid
Public subsidy of €8,000 awarded under the Community of Madrid's programme for the promotion of stable, long-term employment.
Veos Pharmaceuticals S.L. is pleased to announce that it has been awarded a public subsidy in the amount of €8,000 by the Community of Madrid as part of its ongoing commitment to promoting stable, long-term employment in the region.
Programme Details
The funding was granted under the program:
specifically under the action line:
"Incentivos a la contratación indefinida de personas desempleadas de especial atención."
The award is registered under Expediente Nº 09-PIC1-01293.3/2025.
Commitment to Inclusive Hiring
This grant supports the company's continued efforts to foster inclusive hiring practices and contribute to the economic development of the Madrid region through the creation of quality, permanent employment opportunities.
For more information: www.veospharma.com
About Veos Pharmaceuticals
Headquartered in Madrid, Spain, Veos Pharmaceuticals S.L. is a global biotechnology company with a portfolio of nearly 40 products across the EU, US, and Canada. The company specializes in OTC solutions, biostimulants, and advanced nutritional products aimed at improving quality of life.
Veos Pharma's flagship products include Ocufresh®, BioPropello™, OliQuell™, OleoSorb™, VEOX-Preserve™, and ThymoTropin™.
For more information, visit www.veospharma.com.
Media & Investor Contact
Veos Pharmaceuticals, S.L.
Calle Núñez de Balboa, 35 A-5 Planta Oficina A1
28001 Madrid, Spain
Email: info@veospharma.com
Telephone: +34 911 925 649
Website: www.veospharma.com